Overview of AL Amyloidosis
The Inaugural Meeting of the forum provided an overview of AL amyloidosis, and addressed the challenges in clinical trial design for such a complex, multi-systemic disease in a heterogenous population. The meeting established the priorities for future forums.
Understanding AL Amyloidosis
November 30, 2019
Novel Endpoints and Analyses
This series of meetings addressed one of the priority areas identified at the inaugural meeting, development of novel endpoints and analyses for clinical trials in AL amyloidosis.